Press Release European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union 24 August 2026
Press Release Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Lead New Commercialization Unit to Accelerate Growth of Innovative Portfolio 24 August 2026
Press Release ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 24 August 2026
Press Release ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 24 August 2026
Press Release Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking 24 August 2026
Press Release American Chemical Society Names Syngenta’s Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals 24 August 2026
Press Release Primemas Shatters AI Memory Wall at FMS 2026 with CXL Full-Stack Products and Micron Collaboration on the Abaco Project 24 August 2026
Press Release Law Offices of Frank R. Cruz Encourages Taboola.com Ltd. (TBLA) Shareholders To Inquire About Securities Fraud Class Action 24 August 2026
